Lexicon’s Sunny Take Does Not Sway Investors About Phase IIb DPNP Miss

 
• By Joseph Haas
  
Lexicon hopes to move into Phase III in diabetic peripheral neuropathic pain despite mixed Phase IIb data
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Therapy Areas